Figure 10 indicated that the high expression of SPRY1 suggested low risk of lymph node metastasis, whereas the high expression of TGFBI suggested high risk of lymph node metastasis. The gene discussed is TGFBI; the disease is metastatic malignant neoplasm in the lymph nodes.